Literature DB >> 22210186

High-frequency microsatellite instability and BRAF mutation (V600E) in unselected Serbian patients with colorectal cancer.

Srdjan Markovic1, Jadranka Antic, Neda Dragicevic, Richard Hamelin, Zoran Krivokapic.   

Abstract

Microsatellite instability (MSI) is a genetic consequence of a MisMatch Repair defect in colorectal cancer (CRC). We compared clinicopathohistological features with MSI status of CRC and evaluated prognostic significance of MSI status and BRAF mutation in the group of MSI-H tumors. 155 primary CRCs were excised surgically, 2006-2008. MSI analysis was carried out using a fluorescence-based pentaplex polymerase chain reaction technique. BRAF mutation (V600E) was analyzed by direct sequencing in MSI-H tumors. For all patients were evaluated: age, gender, localization, tumor cell type, tumor differentiation, mucin production, lymphocytic infiltration (TILs) and TNM stage. Patients' disease-free survival (DFS) was compared according to MSI and BRAF status using Kaplan-Meier test. Of the 155 CRCs, 19 (12.3%) were MSI-H, and 136 (87.7%) were MSS/L. BRAF mutations were found in 4 of the MSI-H tumors. Patients with MSI-H CRC had lower recurrence rate (log rank test; P = 0.04) than MSS/L group. Patients with MSI-H tumor and BRAF mutation had worse DFS than MSI-H tumors without this mutation (log rank test; P = 0.01). Most of the clinicopathologic characteristics of MSI-H CRC in Serbian patients are similar to those reported in previous studies. Patients with MSI tumor phenotype had favourable prognosis, but in those with BRAF mutation higher recurrence rate was observed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22210186     DOI: 10.1007/s10735-011-9387-6

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  26 in total

1.  Microsatellite instability and the clinicopathological features of sporadic colorectal cancer.

Authors:  R Ward; A Meagher; I Tomlinson; T O'Connor; M Norrie; R Wu; N Hawkins
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

2.  Microsatellite instability and adjuvant fluorouracil chemotherapy: a mismatch?

Authors:  Kimmie Ng; Deborah Schrag
Journal:  J Clin Oncol       Date:  2010-05-24       Impact factor: 44.544

3.  Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients.

Authors:  Jantine L Westra; Michael Schaapveld; Harry Hollema; Jelle P de Boer; Marian M J Kraak; Debora de Jong; Arja ter Elst; Nanno H Mulder; Charles H C M Buys; Robert M W Hofstra; John T M Plukker
Journal:  J Clin Oncol       Date:  2005-08-20       Impact factor: 44.544

Review 4.  Classification of colorectal cancer based on correlation of clinical, morphological and molecular features.

Authors:  J R Jass
Journal:  Histopathology       Date:  2007-01       Impact factor: 5.087

5.  Poorly differentiated colorectal adenocarcinomas show higher rates of microsatellite instability and promoter methylation of p16 and hMLH1: a study matched for T classification and tumor location.

Authors:  Yoshihiro Kazama; Toshiaki Watanabe; Takamitsu Kanazawa; Junichiro Tanaka; Toshiaki Tanaka; Hirokazu Nagawa
Journal:  J Surg Oncol       Date:  2008-03-01       Impact factor: 3.454

Review 6.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

Authors:  C R Boland; S N Thibodeau; S R Hamilton; D Sidransky; J R Eshleman; R W Burt; S J Meltzer; M A Rodriguez-Bigas; R Fodde; G N Ranzani; S Srivastava
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

7.  BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients' outcome.

Authors:  Z Saridaki; D Papadatos-Pastos; M Tzardi; D Mavroudis; E Bairaktari; H Arvanity; E Stathopoulos; V Georgoulias; J Souglakos
Journal:  Br J Cancer       Date:  2010-05-18       Impact factor: 7.640

8.  BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer.

Authors:  Guoren Deng; Ian Bell; Suzanne Crawley; James Gum; Jonathan P Terdiman; Brian A Allen; Brindusa Truta; Marvin H Sleisenger; Young S Kim
Journal:  Clin Cancer Res       Date:  2004-01-01       Impact factor: 12.531

9.  Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancer.

Authors:  Amy J French; Daniel J Sargent; Lawrence J Burgart; Nathan R Foster; Brian F Kabat; Richard Goldberg; Lois Shepherd; Harold E Windschitl; Stephen N Thibodeau
Journal:  Clin Cancer Res       Date:  2008-06-01       Impact factor: 12.531

10.  Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study.

Authors:  Mark A Jenkins; Shinichi Hayashi; Anne-Marie O'Shea; Lawrence J Burgart; Tom C Smyrk; David Shimizu; Paul M Waring; Andrew R Ruszkiewicz; Aaron F Pollett; Mark Redston; Melissa A Barker; John A Baron; Graham R Casey; James G Dowty; Graham G Giles; Paul Limburg; Polly Newcomb; Joanne P Young; Michael D Walsh; Stephen N Thibodeau; Noralane M Lindor; Loïc Lemarchand; Steven Gallinger; Robert W Haile; John D Potter; John L Hopper; Jeremy R Jass
Journal:  Gastroenterology       Date:  2007-04-25       Impact factor: 22.682

View more
  4 in total

Review 1.  Rate of dissemination and prognosis in early and advanced stage colorectal cancer based on microsatellite instability status: systematic review and meta-analysis.

Authors:  James W T Toh; Kevin Phan; Faizur Reza; Pierre Chapuis; Kevin J Spring
Journal:  Int J Colorectal Dis       Date:  2021-02-18       Impact factor: 2.571

2.  Impact of microsatellite status on chemotherapy for colorectal cancer patients with KRAS or BRAF mutation.

Authors:  Chi-Jung Huang; Shih-Hung Huang; Chih-Cheng Chien; Henry Hsin-Chung Lee; Shung-Haur Yang; Chun-Chao Chang; Chia-Long Lee
Journal:  Oncol Lett       Date:  2016-10-18       Impact factor: 2.967

3.  Prognostic value of the combination of microsatellite instability and BRAF mutation in colorectal cancer.

Authors:  Yingchi Yang; Dong Wang; Lan Jin; Guocong Wu; Zhigang Bai; Jin Wang; Hongwei Yao; Zhongtao Zhang
Journal:  Cancer Manag Res       Date:  2018-09-26       Impact factor: 3.989

4.  Clinical and pathological tools for identifying microsatellite instability in colorectal cancer.

Authors:  Zoran Krivokapić; Srdjan Marković; Jadranka Antić; Ivan Dimitrijević; Daniela Bojić; Petar Svorcan; Njegica Jojić; Svetozar Damjanović
Journal:  Croat Med J       Date:  2012-08       Impact factor: 1.351

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.